News

Published on 15 Apr 2024 on Benzinga

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March - Longeveron (NASDAQ:LGVN), Marinus...


Article preview image

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday.

The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&P 500 also fell, dropping, 1.14% to 5,065.04.

NASDAQ.RARE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...

Total Revenue: Reported $109 million in Q1 2024, an 8% increase year-over-year, falling short of ...

GuruFocus.com via Yahoo Finance 5 May 2024

Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and th...

Simply Wall St. via Yahoo Finance 4 May 2024

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript May 2, 2024 Ultrage...

Insider Monkey via Yahoo Finance 4 May 2024

Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y

Ultragenyx Pharmaceutical Inc. RARE incurred a loss of $2.03 per share in the first quarter of 20...

Zacks via Yahoo Finance 3 May 2024

Ultragenyx executive sells shares worth over $15,000 By Investing.com

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EVP and Chief Medical Officer, Eric Crombez, has sol...

Investing.com 3 May 2024

As more rare disease therapies launch, their prices are rising

Rare disease therapies are extremely expensive, with some costing millions of dollars. They are...

Seeking Alpha 16 Apr 2024

Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study

Ultragenyx Pharmaceutical Inc. RARE reported positive interim data from the expansion cohorts of ...

Zacks via Yahoo Finance 16 Apr 2024

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In...

Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharply during Monday’s session after the co...

Benzinga 15 Apr 2024

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March - Longeveron (NASDAQ:LGVN), Marinus...

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Mond...

Benzinga 15 Apr 2024

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday’s...

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Mond...

Benzinga 15 Apr 2024